Vicki Sato
Fortune : 11 M $ au 31/05/2026
Fortune : 11 M $ au 31/05/2026
Le Dr Vicki L. Sato est directrice indépendante chez Akouos, Inc. et présidente non exécutive chez Vir Biotechnology, Inc. et présidente non exécutive chez Denali Therapeutics, Inc. et directrice indépendante principale chez Bristol Myers Squibb Co. et membre du conseil d'administration de The Isabella Stewart Gardner Museum, Inc. Elle siège au conseil d'administration d'Akouos, Inc, de Bristol Myers Squibb Co, de Peer Health Exchange et de Prize4Life, Inc. Le Dr Sato a été précédemment employée en tant que directrice indépendante par BorgWarner, Inc, directrice indépendante par Syros Pharmaceuticals, Inc, directrice indépendante non exécutive par Galapagos NV, professeur par la Harvard Business School, professeur par l'Université de Harvard, directrice indépendante par PerkinElmer, Inc. (États-Unis), présidente de Vertex Pharmaceuticals, Inc, vice-présidente de la recherche de Biogen Idec, Inc, conseillère en affaires d'Atlas Venture, Inc, conseillère de BioVentures Investors, administratrice du Jos Mateo Ballet Theatre et membre du conseil scientifique du Broad Institute, Inc. Elle a également siégé au conseil d'administration de Proclara Biosciences, Inc, Alnylam Pharmaceuticals, Inc, Avila Therapeutics, Inc, Infinity Pharmaceuticals, Inc et Nimbus Therapeutics LLC. Elle a obtenu un diplôme de premier cycle de l'université de Harvard, un diplôme de premier cycle du Radcliffe College et un doctorat de l'université de Harvard.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2026 | 1 078 391 ( 0,64% ) | 10 M $ | 31/05/2026 | |
| 31/03/2026 | 162 575 ( 0,05% ) | 352 788 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/07/2021 |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Analyste en capital-investissement | - |
Peer Health Exchange
Peer Health Exchange Miscellaneous Commercial ServicesCommercial Services Provides health education programs | Directeur/Membre du Conseil | - |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicated to accelerating the discovery of treatments and cures | Directeur/Membre du Conseil | - |
The Isabella Stewart Gardner Museum, Inc.
The Isabella Stewart Gardner Museum, Inc. Other Consumer ServicesConsumer Services The Isabella Stewart Gardner Museum, Inc. is a non-profit company based in Boston, MA. | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Président | 26/05/2026 |
| DENALI THERAPEUTICS INC. | Président | 03/06/2025 |
| AKOUOS | Directeur/Membre du Conseil | 01/12/2022 |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 29 |
|---|---|
BorgWarner, Inc.
BorgWarner, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures combustion, hybrid and electric technologies for light, medium and heavy duty vehicles | Producer Manufacturing |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
The Isabella Stewart Gardner Museum, Inc.
The Isabella Stewart Gardner Museum, Inc. Other Consumer ServicesConsumer Services The Isabella Stewart Gardner Museum, Inc. is a non-profit company based in Boston, MA. | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Prize4Life, Inc.
Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicated to accelerating the discovery of treatments and cures | Commercial Services |
Radcliffe College
Radcliffe College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PerkinElmer U.S. LLC
PerkinElmer U.S. LLC BiotechnologyHealth Technology Develops diverse analytical equipment and applications on chemicals, reagents, standards, media and disposable labware | Health Technology |
Peer Health Exchange
Peer Health Exchange Miscellaneous Commercial ServicesCommercial Services Provides health education programs | Commercial Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio invests in companies located across the globe. The firm focuses on biotech, medtech, real estate, service platforms and digital health sectors. It provides financing in early-stage capital requirements. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national